RXO (RXO) – Investment Analysts’ Recent Ratings Changes
Several brokerages have updated their recommendations and price targets on shares of RXO (NYSE: RXO) in the last few weeks: 5/21/2026 – RXO was downgraded by Weiss Ratings from “sell (d-)” to “sell (e+)”. 5/15/2026 – RXO was upgraded by Stifel Nicolaus from “hold” to “buy”. They now have a $22.00 price target on the […]
Weekly Investment Analysts’ Ratings Changes for Lantern Pharma (LTRN)
Lantern Pharma (NASDAQ: LTRN) recently received a number of ratings updates from brokerages and research firms: 5/23/2026 – Lantern Pharma was upgraded by Wall Street Zen from “sell” to “hold”. 5/22/2026 – Lantern Pharma was downgraded by Weiss Ratings from “sell (d-)” to “sell (e+)”. 5/9/2026 – Lantern Pharma was upgraded by Wall Street Zen […]
Recent Investment Analysts’ Ratings Changes for Assurant (AIZ)
A number of firms have modified their ratings and price targets on shares of Assurant (NYSE: AIZ) recently: 5/26/2026 – Assurant had its price target raised by Piper Sandler from $268.00 to $290.00. They now have an “overweight” rating on the stock. 5/14/2026 – Assurant was upgraded by Morgan Stanley from “equal weight” to “overweight”. […]
Weekly Investment Analysts’ Ratings Changes for ONEOK (OKE)
ONEOK (NYSE: OKE) has recently received a number of price target changes and ratings updates: 5/26/2026 – ONEOK was upgraded by Wall Street Zen from “sell” to “hold”. 5/18/2026 – ONEOK was upgraded by Weiss Ratings from “hold (c+)” to “buy (b-)”. 5/18/2026 – ONEOK was downgraded by Wall Street Zen from “hold” to “sell”. […]
Expeditors International of Washington (EXPD) – Investment Analysts’ Weekly Ratings Changes
Expeditors International of Washington (NASDAQ: EXPD) recently received a number of ratings updates from brokerages and research firms: 5/8/2026 – Expeditors International of Washington had its price target raised by UBS Group AG from $166.00 to $175.00. They now have a “buy” rating on the stock. 5/7/2026 – Expeditors International of Washington was upgraded by […]
Recent Investment Analysts’ Ratings Changes for The Goldman Sachs Group (GS)
A number of firms have modified their ratings and price targets on shares of The Goldman Sachs Group (NYSE: GS) recently: 5/19/2026 – The Goldman Sachs Group had its price target raised by CICC Research from $825.00 to $980.00. They now have an “outperform” rating on the stock. 5/8/2026 – The Goldman Sachs Group was […]
Recent Investment Analysts’ Ratings Changes for Wyndham Hotels & Resorts (WH)
Wyndham Hotels & Resorts (NYSE: WH) has recently received a number of price target changes and ratings updates: 5/12/2026 – Wyndham Hotels & Resorts had its price target raised by Morgan Stanley from $87.00 to $89.00. They now have an “overweight” rating on the stock. 5/4/2026 – Wyndham Hotels & Resorts had its price target […]
Weekly Investment Analysts’ Ratings Changes for Valvoline (VVV)
Several analysts have recently updated their ratings and price targets for Valvoline (NYSE: VVV): 5/11/2026 – Valvoline had its price target raised by Stifel Nicolaus from $42.00 to $44.00. They now have a “buy” rating on the stock. 5/8/2026 – Valvoline had its price target raised by Royal Bank Of Canada from $46.00 to $47.00. […]
Recent Investment Analysts’ Ratings Changes for Enovix (ENVX)
Several analysts have recently updated their ratings and price targets for Enovix (NASDAQ: ENVX): 5/16/2026 – Enovix was upgraded by Wall Street Zen from “strong sell” to “sell”. 5/14/2026 – Enovix had its “buy” rating reaffirmed by TD Cowen. 5/14/2026 – Enovix had its price target lowered by Oppenheimer Holdings, Inc. from $24.00 to $21.00. […]
Investment Analysts’ Weekly Ratings Changes for HubSpot (HUBS)
A number of firms have modified their ratings and price targets on shares of HubSpot (NYSE: HUBS) recently: 5/11/2026 – HubSpot was downgraded by BNP Paribas Exane from “outperform” to “neutral”. They now have a $210.00 price target on the stock. 5/11/2026 – HubSpot had its price target lowered by Barclays PLC from $300.00 to […]
Recent Investment Analysts’ Ratings Changes for Jade Biosciences (JBIO)
Jade Biosciences (NASDAQ: JBIO) has recently received a number of price target changes and ratings updates: 5/11/2026 – Jade Biosciences was downgraded by Weiss Ratings from “sell (d)” to “sell (d-)”. 5/11/2026 – Jade Biosciences had its price target raised by Guggenheim from $23.00 to $32.00. They now have a “buy” rating on the stock. […]
Moderna (MRNA) – Investment Analysts’ Weekly Ratings Changes
Moderna (NASDAQ: MRNA) has recently received a number of price target changes and ratings updates: 5/4/2026 – Moderna had its price target raised by UBS Group AG from $36.00 to $45.00. They now have a “neutral” rating on the stock. 5/4/2026 – Moderna had its price target raised by Royal Bank Of Canada from $35.00 […]
Investment Analysts’ Weekly Ratings Changes for EastGroup Properties (EGP)
Several brokerages have updated their recommendations and price targets on shares of EastGroup Properties (NYSE: EGP) in the last few weeks: 5/5/2026 – EastGroup Properties had its price target raised by Truist Financial Corporation from $205.00 to $215.00. They now have a “buy” rating on the stock. 4/29/2026 – EastGroup Properties had its price target […]
last updated on 29 May 21:56